ACC 2014 Report: Benefits of treating heart attack patients with a cheap drug
The 6-month follow-up data from the METOCARD-CNIC trial are published in the Journal of the American College of Cardiology.
The 6-month follow-up data from the METOCARD-CNIC trial are published in the Journal of the American College of Cardiology.
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death,… read more.
Report from the ACC Annual Scientific Meeting, 29 – 31 March 2014 in Washington. Angiotensin-converting-enzyme (ACE) inhibitors are associated with reduced mortality and cardiovascular events in patients with… read more.
Poster Presentation: Study of alemtuzumab induction with tacrolimus maintenance monotherapy compared to IL2R blockade with tacrolimus/MMF maintenance in kidney transplantation by Adam McLean, Imperial College Kidney & Transplant… read more.
Quality assessment of human kidneys using ex-vivo normothermic perfusion by Adam Barlow, University Hospitals of Leicester – Ex-vivo normothermic perfusion is a viable method of preserving kidneys for… read more.
Maria Dalby reporting on the Oral Presentation by Mari Kilner, Freeman Hospital, Newcastle upon Tyne- Thromboelastography is a method of testing the efficiency of coagulation which measures not… read more.
Maria Dalby reporting on the Oral Presentation by Marc Clancy, Western Infirmary, Glasgow – Although the mainstay of clinical immunosuppression since the 1980s, calcineurin inhibitors (CNIs) are narrow… read more.
Maria Dalby reporting on the Oral Presentation by Lluís Guirado, Fundació Puigvert, Barcelona, Spain. Renal function is a strong predictor of patient and graft survival after renal transplantation,… read more.
Maria Dalby reporting on the Oral Presentation by Phanibhushana Munipalle, Southmead Hospital, Bristol. Altruistic organ donation, that is, where a person volunteers to donate a kidney for transplantation… read more.
Efficacy and Safety of Prescribing in Transplantation (ESPRIT) Group, Barts and the London School of Medicine and Dentistry, London by Atholl Johnston.
by Maria Dalby – Transplantation across the immune barrier is becoming increasingly common, but constitutes a risk factor for the development of donor-specific antibodies and thus for long-term… read more.
Maria Dalby reporting from the annual British Transplantation Society meeting in Glasgow by Anthony Dorling, King’s College London – Chronic rejection is a major cause of graft failure… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.